Media coverage of Michael Honsue Cho
Third-party press and recognition alongside company announcements and publications. Each card links to the original source.
June 2024
Invion Ltd Announces Share Ownership Transfer
Reports the transfer of Invion shares from RMW Cho Health Technology Limited, noting no impact on the ownership held by RMW Cho Group's Chairman, Michael Cho.
October 2024
Biocurious: Invion taps the power of light to zap solid tumours
Covers the Photosoft platform developed by Melbourne businessman Michael Cho's RMW Cho Group, and its application across multiple diseases including rare anogenital cancers.
March 2024
Invion Reports Positive Pre-Clinical Outcome for INV043
Reports Peter MacCallum Cancer Centre findings on INV043 combined with immune checkpoint inhibitor therapy, with comment from Michael Cho as founder of RMW Cho Group and originator of Photosoft.
September 2025
Ink Nurse secures angel investment for expansion into North America
Reports Ink Nurse securing a seven-figure investment from angel investor Michael Cho to fund expansion into North America.
March 2026
Apple iSports Signs Joint Venture Agreement with Apple iCasino
Reports the joint venture agreement between Apple iSports and AiC Enterprises, to be led by Michael Cho.
April 2026
Identification and characterization of phyllochlorin sodium as a novel chlorin-derived photosensitiser
Peer-reviewed research identifying a novel chlorin-derived photosensitising agent, co-authored by Honsue Cho of RMW Cho Ltd with researchers from Hudson Institute of Medical Research, Monash University and Advanced Molecular Technologies.
March 2026
Apple iSports Signs Joint Venture Agreement with Apple iCasino
Announces the joint venture agreement between Apple iSports and AiC Enterprises, to be led by Michael Cho.
September 2025
Ink Nurse secures seven-figure funding to fuel expansion
Announces that Ink Nurse has secured seven-figure funding to fuel its expansion.
Read the full story of Michael Honsue Cho, explore the photodynamic therapy research behind the coverage, or see his investments and ventures.